Aedifica/€AED

05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX

About Aedifica

Aedifica is a Belgian real estate investment trust (REIT) specializing in the healthcare real estate sector, particularly in elderly care homes. Founded in 2005 and headquartered in Brussels, Belgium, Aedifica's portfolio spans several European countries, including Belgium, the Netherlands, Germany, Finland, and the United Kingdom. The company focuses on acquiring, developing, and managing properties that meet the needs of Europe’s aging population, positioning itself strategically within the healthcare infrastructure space. Aedifica's competitive strengths lie in its specialization in a growing sector, comprehensive market knowledge, and long-standing relationships with care home operators. These capabilities enable it to effectively navigate the challenges and opportunities within the healthcare real estate market. Sources: Aedifica company website and annual reports.

Ticker

€AED

Primary listing

BSE

Employees

131

Aedifica Metrics

BasicAdvanced
€3B
17.07
€3.70
0.94
€2.73
4.33%

What the Analysts think about Aedifica

Majority rating from 16 analysts.
Buy

Bulls say / Bears say

Aedifica’s planned merger with Cofinimmo will form Europe’s largest REIT, with a combined gross asset value of €12.1 billion and accretive EPRA earnings per share for all shareholders. (Reuters)
Aedifica’s 2024 annual results showed EPRA earnings of €234.6 million, up 7% YoY, and rental income of €338.1 million, up 8% YoY, with full occupancy and a 19-year weighted average unexpired lease term. (MarketScreener)
Barclays upgraded Aedifica to Overweight from Underweight and increased its target price to €74, reflecting higher confidence in the company’s growth prospects. (Reuters)
BNP Paribas Exane downgraded Aedifica from Neutral to Underperform on January 5, 2025, citing concerns about its near-term earnings outlook. (Nasdaq)
JPMorgan lowered its rating on Aedifica from Overweight to Neutral with a revised price target of €69 on April 2, 2025, indicating reduced confidence in further stock gains. (MarketScreener)
The start of the proposed exchange offer for the Cofinimmo merger is not expected until around September 1, 2025, pending regulatory and shareholder approvals, which adds execution and timing risks. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 5 Sept 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €AED

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs